Published by Josh White on 11th May 2017
(ShareCast News) - Developer of immunotherapies for the treatment of cancer, Scancell Holdings, announced a proposed placing of new ordinary shares in the company with existing and new institutional and professional investors on Thursday, to raise up to £5m.
URL: http://www.digitallook.com/dl/news/story/25922806/...